Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maya Miller

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Scientific American|July 19, 2018
Quick HitsMaya Miller
Scientific American|October 2, 2018
Quick HitsMaya Miller
Scientific American|October 2, 2018
Body BalanceMaya Miller
RSC Advances|February 5, 2019
Racemic <i>vs.</i> enantiopure inert Ti(iv) complex of a single diaminotetrakis(phenolato) ligand in anticancer activity toward human drug-sensitive and -resistant cancer cell linesMaya Miller, Edit Y Tshuva
Metal Ions in Life Sciences|February 3, 2018
Coordination Complexes of Titanium(IV) for Anticancer TherapyEdit Y Tshuva, Maya Miller
Scientific Reports|June 28, 2018
Synthesis of Pure Enantiomers of Titanium(IV) Complexes with Chiral Diaminobis(phenolato) Ligands and Their Biological ReactivityMaya Miller, Edit Y Tshuva
Journal of Inorganic Biochemistry|April 20, 2016
Insights into molecular mechanism of action of salan titanium(IV) complex with in vitro and in vivo anticancer activityMaya Miller, Ori Braitbard, Jacob Hochman, et al.
Iscience|August 2, 2020
ACE2 Co-evolutionary Pattern Suggests Targets for Pharmaceutical Intervention in the COVID-19 PandemicMaya Braun, Elad Sharon, Irene Unterman, et al.
ACS Applied Bio Materials|January 15, 2022
Electrochemical Triggered Dissolution of Hydroxyapatite/Doxorubicin NanocarriersOri Geuli, Maya Miller, Avia Leader, et al.
Dalton Transactions (Cambridge, England : 2003)|December 6, 2018
Cytotoxic homoleptic Ti(iv) compounds of ONO-type ligands: synthesis, structures and anti-cancer activityRajesh Manne, Maya Miller, Andrew Duthie, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Scientific American|July 19, 2018
Quick HitsMaya Miller
Scientific American|October 2, 2018
Quick HitsMaya Miller
Scientific American|October 2, 2018
Body BalanceMaya Miller
RSC Advances|February 5, 2019
Racemic <i>vs.</i> enantiopure inert Ti(iv) complex of a single diaminotetrakis(phenolato) ligand in anticancer activity toward human drug-sensitive and -resistant cancer cell linesMaya Miller, Edit Y Tshuva
Metal Ions in Life Sciences|February 3, 2018
Coordination Complexes of Titanium(IV) for Anticancer TherapyEdit Y Tshuva, Maya Miller
Scientific Reports|June 28, 2018
Synthesis of Pure Enantiomers of Titanium(IV) Complexes with Chiral Diaminobis(phenolato) Ligands and Their Biological ReactivityMaya Miller, Edit Y Tshuva
Journal of Inorganic Biochemistry|April 20, 2016
Insights into molecular mechanism of action of salan titanium(IV) complex with in vitro and in vivo anticancer activityMaya Miller, Ori Braitbard, Jacob Hochman, et al.
Iscience|August 2, 2020
ACE2 Co-evolutionary Pattern Suggests Targets for Pharmaceutical Intervention in the COVID-19 PandemicMaya Braun, Elad Sharon, Irene Unterman, et al.
ACS Applied Bio Materials|January 15, 2022
Electrochemical Triggered Dissolution of Hydroxyapatite/Doxorubicin NanocarriersOri Geuli, Maya Miller, Avia Leader, et al.
Dalton Transactions (Cambridge, England : 2003)|December 6, 2018
Cytotoxic homoleptic Ti(iv) compounds of ONO-type ligands: synthesis, structures and anti-cancer activityRajesh Manne, Maya Miller, Andrew Duthie, et al.
Pageof 2